Atreca (BCEL) has a profit margin of -361.51%, below the Healthcare sector average of 15.52%.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2023
Trailing 12 months ending Sep 2023
Atreca's profit margin stands at -361.51% as of September 2023. That is below the Healthcare sector average of 15.52%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Atreca sits lower the Healthcare benchmark (15.52%) with a profit margin of -361.51%. That is roughly 233028.3% below the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.
A profit margin of -361.51% for Atreca means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.
The history chart shows how Atreca's profit margin evolved across reporting periods, while the comparison chart places BCEL next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, profit margin is commonly used to spot outliers. Atreca's reading of -361.51% (sector avg 15.52%) is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.